Owlstone Medical's Series A Round

Owlstone Medical raised a round of funding on June 28, 2016. Investors include Medtekwiz Advisory.

Owlstone Medical leverages proprietary and proven Field Asymmetric Ion Mobility Spectrometry (FAIMS) technology to develop and commercialize a breathalyzer for use in clinical diagnostics and precisio…

Articles about Owlstone Medical's Series A Round: